InChI=1S/C40H48N4O3/c1-4-23-21-43-17-15-40-30-11-7-9-13-32(30)44-37(40)29(27(23)19-34(40)43)22-47-38(44)35(39(45)46-3)28-18-33-36-26(14-16-42(33)20-24(28)5-2)25-10-6-8-12-31(25)41-36/h5-13,23,27-29,33-35,37-38,41H,4,14-22H2,1-3H3/b24-5-/t23-,27+,28+,29+,33+,34+,35-,37+,38+,40-/m1/s1 |
ISDWYSGTYITCHG-OCNKQYNFSA-N |
[H][C@@]1(CC)CN2CC[C@@]34c5ccccc5N5[C@@]([H])(OC[C@@]([H])([C@@]1([H])C[C@]23[H])[C@@]45[H])[C@]([H])(C(=O)OC)[C@@]1([H])C[C@]2([H])N(CCc3c2[nH]c2ccccc32)C\C1=C\C |
|
EC 3.1.1.7 (acetylcholinesterase) inhibitor
An EC 3.1.1.* (carboxylic ester hydrolase) inhibitor that interferes with the action of enzyme acetylcholinesterase (EC 3.1.1.7), which helps breaking down of acetylcholine into choline and acetic acid.
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via alkaloid )
|
|
View more via ChEBI Ontology
methyl (2R)-[(3aR,9S,11aS,11bS,12S,13aS,14S)-14-ethyl-2,3,11a,12,13,13a-hexahydro-11H,11bH-1,12-ethano[1,3]oxazino[3,4,5-lm]pyrrolo[2,3-d]carbazol-9-yl][(2R,3E,12bS)-3-ethylidene-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl]acetate
|
Geissospermine
|
KEGG COMPOUND
|
427-01-0
|
CAS Registry Number
|
KEGG COMPOUND
|
427-01-0
|
CAS Registry Number
|
ChemIDplus
|
76217
|
Reaxys Registry Number
|
Reaxys
|
13231363
|
PubMed citation
|
Europe PMC
|
13685183
|
PubMed citation
|
Europe PMC
|
13685184
|
PubMed citation
|
Europe PMC
|
13863306
|
PubMed citation
|
Europe PMC
|
14435279
|
PubMed citation
|
Europe PMC
|
19463267
|
PubMed citation
|
Europe PMC
|
20844909
|
PubMed citation
|
Europe PMC
|
|